Overview

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

Status:
Completed
Trial end date:
2017-07-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics of BMS-986177 in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb